CROI 2015 Program and Abstracts

Poster Listings

WEDNESDAY, FEBRUARY 25, 2015 Session P-N5 Poster Session

670 Does the Availability of New DAAs Influence Treatment Uptake in Acute Hepatitis C in HIV Coinfection? Christoph Boesecke 1 ; Mark Nelson 2 ; Patrick Ingiliz 5 ;Thomas Lutz 3 ; Stefan H. Scholten 4 ; Christoph D. Spinner 6 ; Michael Rausch 9 ;Thomas Reiberger 7 ; Stefan Mauss 8 ; Jürgen Rockstroh 1 1 Bonn University Hospital, Bonn, Germany; 2 Chelsea and Westminster Hospital, NHS Foundation Trust, London, United Kingdom; 3 Infektiologikum, Frankfurt/Main, Germany; 4 Praxis Hohenstaufenring, Cologne, Germany; 5 MiB, Berlin, Germany; 6 Interdisciplinary HIV Centre (IZAR), University Hospital Klinikum Rechts der Isar, Munich, Germany; 7 Medical University of Vienna, Vienna, Austria; 8 Center for HIV and Hepatogastroenterology, Duesseldorf, Germany; 9 Aerztezentrum Nollendorfplatz, Berlin, Germany 671 Long-Term Follow-Up of HIV-Positive MenWho Have Sex With Men (MSM) With Acute Hepatitis C Virus (HCV) Infection: High Rates of Treatment and Low Rates of Liver-Related Complications Patrick Ingiliz 1 ; Anders C. Boyd 3 ; Katharina Steininger 1 ; Andreas Carganico 1 ; Stephan Dupke 1 ; Ivanka Krznaric 1 ; Marcel Schuetze 1 ; Stefan Neifer 2 ; Martin J. Obermeier 1 ; Axel Baumgarten 1 1 Medical Center for Infectious Diseases, Berlin, Germany; 2 Microbiology Laboratory, Berlin, Germany; 3 INSERM UMR_S 1136, Paris, France 672 Hepatitis C in MenWho Have Sex with MenWith New HIV Diagnoses in Los Angeles KaraW. Chew 1 ; Marjan Javanbakht 2 ; Laurel Clare 1 ; Lorelei Bornfleth 1 ; Debika Bhattacharya 1 ; Pamina Gorbach 2 ; Martha L. Blum 3 1 David Geffen School of Medicine at UCLA, Los Angeles, CA, US; 2 UCLA Fielding School of Public Health, Los Angeles, CA, US; 3 Community Hospital of the Monterey Peninsula, Monterey, CA, US 673 Development and Comparison of Hepatitis C Cross-Sectional Incidence Testing Methods Eshan U. Patel 1 ; Andrea Cox 2 ; Shruti H. Mehta 3 ; Caroline E. Mullis 2 ; Jeffrey Quinn 2 ; Gregory D. Kirk 3 ;Thomas C. Quinn 1 ; Oliver B. Laeyendecker 1 1 National Institute of Allergy and Infectious Diseases (NIAID), Baltimore, MD, US; 2 Johns Hopkins University School of Medicine, Baltimore, MD, US; 3 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US 674 Risk Factors for Transmission of HCV Among HIV-Infected MSM: A Case- Control Study Joost W. Vanhommerig 1 ; Femke A. Lambers 1 ; Janke Schinkel 2 ; Joop E. Arends 3 ; Fanny N. Lauw 4 ; Kees Brinkman 5 ; Luuk Gras 6 ; Bart J. Rijnders 7 ; JanT. van der Meer 2 ; Maria Prins 1 1 GGD Amsterdam, Amsterdam, Netherlands; 2 Academic Medical Center, Amsterdam, Netherlands; 3 University Medical Center Utrecht, Utrecht, Netherlands; 4 Slotervaart Hospital, Amsterdam, Netherlands; 5 OLVG Hospital, Amsterdam, Netherlands; 6 Dutch HIV Monitoring Foundation, Amsterdam, Netherlands; 7 Erasmus University Medical Center, Rotterdam, Netherlands; 8 Academic Medical Center, Amsterdam, Netherlands 675 Behavioural and Treatment Interventions to Reduce HCV Transmissions in HIV+MSM Luisa Salazar-Vizcaya 1 ; Roger Kouyos 2 ; Cindy Zahnd 1 ; Manuel Battegay 3 ; Katharine Darling 4 ; Alexandra Calmy 5 ; Pietro L.Vernazza 6 ; Olivia Keiser 1 ; Andri Rauch 7 On behalf of the Swiss HIV Cohort Study 1 University of Bern, Bern, Switzerland; 2 University Hospital Zurich, Zürich, Switzerland; 3 University Hospital Basel, Basel, Switzerland; 4 Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 5 Geneva University Hospitals, Geneva, Switzerland; 6 Kantonsspital St Gallen, St Gallen, Switzerland; 7 University Hospital Bern, Inselspital, Bern, Switzerland 2:30 pm– 4:00 pm Immunopathogenesis of HCV Infection 676 Macrophage Activation and Hepatitis C (HCV) Disease Progression in HIV- InfectedWomen Participating in theWomen’s Interagency HIV Study (WIHS) Audrey L. French 1 ; Charlesnika Evans 3 ; Marion G. Peters 2 ; Mary A.Young 4 ; Mark Kuniholm 6 ; Michael Augenbraun 7 ; Seema N. Desai 5 1 CORE Center/ Stroger Hospital of Cook County, Chicago, IL, US; 2 University of California San Francisco, San Francisco, CA, US; 3 Northwestern University, Chicago, IL, US; 4 Georgetown University, Washington, IL, US; 5 Rush University Medical Center, Chicago, IL, US; 6 Montefiore Medical Center, University Hospital for Albert Einstein College of Medicine, Bronx, NY, US; 7 State University of New York Downstate, Brooklyn, NY, US Session P-N7 Poster Session Poster Hall

Poster Hall

2:30 pm– 4:00 pm HCV: Epidemiology and Case Detection 662 Hepatitis C and B Testing Among HIV-Infected Individuals in England Sam Lattimore ; Sarah Collins; Celia Penman; Lukasz Cieply; Sema Mandal

Sentinel Surveillance of Blood-BorneVirusTesting Public Health England, London, United Kingdom

663 WITHDRAWN 664 HCV 2k/1b Recombinant Form among Hepatitis C–Infected Genotype 2 Patients in Georgia Marika Karchava 1 ; JesperWaldenstrom 2 ; Monica M. Parker 3 ; Renee Hallack 3 ; Lali Sharvadze 1 ; Lana Gatserelia 1 ; Nikoloz Chkhartishvili 1 ; Natia Dvali 1 ; Helen Norder 2 ;Tengiz Tsertsvadze 1 1 Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; 2 Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; 3 Wadsworth Center, Albany, NY, US 665 High HCV Prevalence Among Baby Boomers in Surveillance-Identified High HIV Risk Areas Irene Kuo 1 ; MeriamMikre 1 ; A.ToniYoung 2 ; Geoffrey Maugham 2 ; Amanda D. Castel 1 1 George Washington University, Washington, DC, US; 2 Community Education Group, Washington, DC, US 666 Low HCV Screening Uptake of the Current Birth Cohort Testing Guidelines Alexander G. Geboy 1 ; Hyun A. Cha 1 ; Idene E. Perez 1 ; MatthewT. Bell 1 ; Sandeep Mahajan 2 ; Adebisi O. Ayodele 2 ; Dawn A. Fishbein 2 1 MedStar Health Research Institute, Hyattsville, MD, US; 2 MedStar Washington Hospital Center, Washington, DC, US 667 Evaluation of CDC Recommendations for HCV Testing in an Urban Emergency Department Yu-Hsiang Hsieh 3 ; Richard Rothman 3 ; Oliver B. Laeyendecker 2 ; Gabor Kelen 3 ; Ama Avornu 3 ; Eshan U. Patel 2 ; Jim Kim 3 ; Risha Irvin 3 ; David L.Thomas 3 ;Thomas C. Quinn 2 1 Johns Hopkins University School of Medicine, Baltimore, MD, US; 2 National Institute of Allergy and Infectious Diseases, Baltimore, MD, US; 3 Johns Hopkins University School of Medicine, Baltimore, MD, US 668 Impact of Integrating EMR HCV Testing Prompts in a Difficult to Navigate EMR System Stephanie Tzarnas 2 ; Monique Allen 2 ; Allison Brodsky 2 ; Gregory Johnson 2 ; Lora Magaldi 2 ; Carolyn Moy 2 ; NancyTursi 2 ; Steven Zivich 2 ; StaceyTrooskin 2 1 Drexel University College of Medicine, Philadelphia, PA, US; 2 Drexel University College of Medicine, Philadelphia, PA, US; 3 Drexel University College of Medicine, Philadelphia, PA, US; 4 Drexel University College of Medicine, Philadelphia, PA, US 2:30 pm– 4:00 pm Acute HCV Infection 669 SVR12 Results After 12w Boceprevir + P/R in the Dutch Acute Hepatitis C in HIV Study Sebastiaan J. Hullegie 8 ; Mark A. Claassen 8 ; Guido E. van den Berk 2 ; JanT. van der Meer 1 ; Joop E. Arends 3 ; Clemens Richter 4 ; Dirk Posthouwer 5 ; Peter P. Koopmans 6 ; Fanny N. Lauw 7 ; Bart J. Rijnders 8 1 Academic Medical Center University of Amsterdam, Amsterdam, Netherlands; 2 Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands; 3 University Medical Center Utrecht, Utrecht, Netherlands; 4 Rijnstate Ziekenhuis, Arnhem, Netherlands; 5 Maastricht University Medical Center, Maastricht, Netherlands; 6 Radboud University Medical Center, Nijmegen, Netherlands; 7 Slotervaart Ziekenhuis, Amsterdam, Netherlands; 8 Erasmus University Medical Center, Rotterdam, Netherlands Session P-N6 Poster Session Poster Hall

Poster Listings

53

CROI 2015